Key Takeaways
Treat patents as government-created monopolies, not ordinary property rights
Separate ownership from control. The book distinguishes owning a copy of an idea from controlling how everyone else may use their copies. Buying a book or a machine gives its owner ordinary property rights: they can use it, sell it, or make changes. Patent and copyright law go further, allowing holders to restrict other people’s use of independently acquired copies. The authors call this broader power intellectual monopoly. Their objection is not that creators should work for nothing, but that paying creators by granting exclusion can also limit competition and follow-on innovation.
Keep trademarks distinct. A trademark identifies who provides a product; it does not need to prevent people from copying the product itself. The authors see a clearer economic case for preventing deception about a product’s source than for controlling all uses of an idea. This distinction makes the debate more precise: secure creators’ own copies and identities, but question the legal power to govern everyone else’s copies.
The distinction is valuable because the phrase intellectual property can make very different legal powers sound like one natural right. Separating attribution, ownership, and exclusion allows each to be assessed on its own merits. The harder question is where the boundaries sit in practice: copying that falsely presents another person’s work as one’s own is different from copying while clearly crediting the source. A sound policy must protect against fraud without treating every act of imitation as theft. The book’s framing helps expose that choice, though it does not by itself settle every boundary case.
A patent can reward an inventor while delaying useful descendants of the invention
Watt’s engine had rivals. James Watt developed a separate condenser for steam engines, then obtained patents and, with partner Matthew Boulton, extended protection through 1800. The book estimates that Britain added about 750 horsepower of steam engines per year during the patent period, compared with more than 4,000 per year after it expired. Engine efficiency changed little under the monopoly, then rose roughly fivefold between 1810 and 1835. The authors argue that Watt’s patent blocked competitors’ improvements, including Jonathan Hornblower’s compound engine and the high-pressure engine.
The restriction cut both ways. A separate patent held by James Pickard prevented Watt from using the more efficient crank-and-flywheel arrangement, so he devised an alternative. After Pickard’s patent expired, Boulton and Watt adopted the crank. The authors also note that their firm continued to win orders after Watt’s patents ended, despite new competition.
The Watt story makes a general mechanism visible: a right intended to reward one advance can also restrict the combinations that produce the next one. That is especially consequential in technologies built from interdependent components. The historical numbers are suggestive, but they do not isolate patents from every other cause of steam adoption or efficiency gains. The book acknowledges that historians dispute aspects of its interpretation. The durable lesson is not that Watt contributed nothing, but that judging a patent requires counting both the invention it may encourage and the improvements it may block.
Competition can fund innovation without making creators work for free
Creation flourished without patents. The book points to the software industry’s early growth before software patents became available in the United States. Foundational tools such as graphical interfaces, compilers, databases, and programming languages emerged in that period. Open-source projects offer another example: contributors share source code, and businesses can earn revenue through support, customization, and reliability. The book’s historical examples extend beyond software, from fashion to financial products and news.
A free copy need not mean no income. The 9/11 Commission Report was available online without copyright, yet publishers sold millions of printed copies and competing editions. English authors in the nineteenth century also sometimes earned more from U.S. publishers, where their books could be freely reprinted, than from royalties at home. First access, trusted production, speed, and service can all have commercial value even when copying is permitted.
These examples widen the idea of compensation beyond royalties. Markets reward not only exclusive rights, but also expertise, reputation, service, and being first to meet demand. Open-source software makes the distinction especially clear: access to code can be free while maintenance and integration remain valuable. Yet evidence that some creators succeed without exclusion does not prove every creator can do so, or that every business model scales equally well. The useful question is comparative: which revenue sources can support a particular kind of creation while leaving room for others to build on it?
Sell the scarce first copy, not a permanent right to exclude
Competition can leave a return. The authors use competitive rents to describe earnings above the cost of making one more copy, generated when productive capacity is limited relative to demand. A new book, seed variety, or machine cannot instantly be reproduced at unlimited scale. The first supplier can sell early copies at a premium, while later entrants invest in the capacity and expertise needed to compete. The resulting price advantage can help repay the original effort without giving the inventor permanent control over every later copy.
Being first has other rewards. A creator may profit from expertise, consulting, live performances, signed editions, or advertising. The book notes that authors’ sales often concentrate soon after release, and musicians can earn from concerts even when recordings are copied. These channels vary by industry, but they show why the choice is not simply monopoly or zero compensation.
This account shifts attention from abstract ideas to the real assets and bottlenecks around them: prototypes, skilled labor, production capacity, and customer trust. It also explains why copying does not instantly erase every first-mover advantage. The limit is the book’s own concept of indivisibility: an invention may require a large up-front investment while serving a small market, leaving too little competitive return. Whether that problem is common enough to justify exclusion is an empirical question, not something the model resolves automatically.
When ideas build on ideas, patent thickets tax the next invention
Exclusion can compound. A patent thicket is a dense web of overlapping claims that makes it hard to develop a product without negotiating with multiple rights holders. The book describes software firms acquiring patents defensively, so they can bargain or threaten counter-suits when challenged. A Carnegie survey found patents were rated effective for appropriating returns by about 35% of firms for product innovation and 23% for process innovation. Firms also reported using patents to block competitors, prevent suits, and strengthen bargaining positions.
The cost reaches beyond lawyers. Patent searches, licensing negotiations, and the threat of litigation can discourage products from reaching the market. In fields where new work depends on existing components, each exclusion adds to the cost of the next step. The book calls the resulting loss of innovation and diffusion IP-inefficiency. It argues that defensive patenting can consume resources even when firms themselves regard many patents as tools for bargaining rather than useful inventions.
The thicket problem is a form of cumulative friction: each right may look limited on its own, yet the total clearance burden can become substantial. This is particularly important in complex products assembled from many technologies. The account also clarifies why a patent portfolio can be privately useful as leverage while socially wasteful overall. Still, patenting and bargaining are not identical across industries, and the examples do not establish that every portfolio creates a serious barrier. Policy should focus on whether claims are clear, independently developed, and genuinely necessary to the product.
Judge innovation policy by useful output, not patent counts
More patents are not proof. The book reviews studies of patent reforms and concludes that stronger patent rights reliably increase patenting, but show weak or no evidence of increasing innovation. A survey of firms found secrecy, lead time, and manufacturing or sales capabilities were often more effective ways to capture returns than patents. In nineteenth-century World Fairs, countries without patent systems produced substantial numbers of innovations, and their exhibits won a disproportionate share of medals.
Look at what changed. U.S. patent grants roughly tripled between 1983 and 2003, but the authors find no comparable rise in productivity attributable to that expansion. In agriculture, U.S. productivity growth was similar before and after 1970, when protection for plant varieties expanded. Corn yields rose substantially before corn patents became widespread. These comparisons challenge the claim that more legal protection automatically produces more useful innovation.
The measurement point is essential: a patent is a legal event, not a direct measure of a better product, wider access, or faster productivity growth. Historical comparisons and firm surveys help test the incentive claim rather than simply assume it. They also have limits. Patent reforms often coincide with other economic changes, and productivity measures can miss benefits that are hard to quantify. The strongest conclusion is therefore narrower than a universal verdict: patent counts alone cannot demonstrate social gains, so evaluation needs outcomes such as useful adoption, follow-on research, and consumer access.
Copyright extensions preserve corporate control, not incentives for already-created works
Retroactive rewards cannot change past choices. The 1998 U.S. Copyright Term Extension Act added 20 years of protection to existing works as well as new ones. The book cites an economic calculation estimating that the extension increased the present value of payments to a living author by only about 0.33%, because the extra royalties would arrive far in the future. For works already created, however, retroactive extension could not have motivated their creation.
Protection can also hide works. Copyright may keep older books, films, and music under exclusive control even when their owners no longer sell them. The authors highlight orphan works, whose rights holders are difficult or impossible to locate, and argue that extended terms can keep these works unavailable to new publishers and creators. Their objection is not only higher prices, but the loss of access and reuse across culture.
The distinction between prospective and retroactive protection is a useful test of incentive claims. A reward added after a work exists may transfer income without changing the decision to create it. The public-domain argument also points to a less visible cost: works can be legally controlled yet commercially neglected. A practical complication is that investment in restoring and distributing old work can require funding. That challenge supports precise tools for rewarding restoration, not necessarily blanket extensions that cover every work regardless of whether it is available.
Let independent inventors compete instead of awarding one legal winner
Discovery is often simultaneous. The book argues that important inventions commonly emerge from several people working toward similar solutions. Its radio history describes Marconi’s claims alongside earlier or competing work by Nikola Tesla, Oliver Lodge, Aleksander Popov, and Henry Jackson. The Wright brothers also used patents to challenge Glenn Curtiss, whose work on movable flight controls contributed to later aircraft. In each case, legal priority could determine who controlled a market, even when technical progress came from a wider field of contributors.
A single winner can narrow production. When one claimant receives broad rights, other inventors may be blocked from developing or selling their own versions. The authors argue that allowing independent invention as a defense to infringement would reduce this risk. Their point is not that every competing claim is equally strong, but that a race to obtain legal priority can obscure cumulative work and waste useful capacity.
This is a reminder that invention is often a process of convergence rather than a solitary lightning strike. In modern technical fields, multiple teams can face the same scientific constraints and reach similar designs independently. Legal systems must decide how to distinguish genuine copying from parallel discovery, a difficult task when records are incomplete. The book’s proposed independent-invention defense addresses a real fairness problem, but proof standards matter: a rule too easy to invoke could undermine legitimate claims, while one too strict can preserve a patent-holder’s accidental windfall.
In drug development, patents can fund rent-seeking as readily as cures
The industry is not one simple case. Drug patents are often defended by pointing to high development costs, including estimates near $800 million for bringing a new drug to market. The authors question those estimates’ methods and note that much spending goes to clinical trials, marketing, and drugs that resemble existing treatments. They cite an analysis of FDA approvals from 1989 to 2000 in which about 77% of approved drugs were not judged to offer a substantial clinical improvement over existing treatments.
Many medical advances had other origins. Of 46 top-selling drugs examined in the book, its authors judged that 20 did not meaningfully depend on patents. They also describe Italy’s pharmaceutical industry, which operated without product patents until 1978, and argue that its adoption of patents did not produce a clear increase in innovative drugs. The authors propose publicly financed clinical trials as one alternative to relying on long drug monopolies.
Pharmaceuticals test the argument because high fixed costs and urgent human need coexist. The book usefully separates the cost of discovering a compound from the cost of proving its safety and effectiveness, and from marketing it. Those distinctions matter for designing alternatives. But the historical comparisons do not prove that patent removal alone would preserve every valuable research program, especially when clinical testing rules remain in place. The authors’ proposal to fund trials publicly is therefore more persuasive as part of a coordinated policy redesign than as a stand-alone cure.
Shrink intellectual monopolies gradually, while funding research more directly
Change the system in sequence. The authors oppose an abrupt abolition that ignores institutions built around current patent and copyright rules. They propose reducing protection over time, strengthening defenses against frivolous or submarine patents, and allowing independent invention to defeat infringement claims. For copyright, they support ways to return abandoned or orphaned works to use. They distinguish trademarks, which identify the source of goods, from patents and copyrights, which restrict uses of ideas.
Fund the work, not the exclusion. For pharmaceuticals, they suggest that public agencies finance costly clinical trials and make results available, reducing the rationale for long drug patents. More broadly, they discuss research subsidies and prizes as possible alternatives when private returns are insufficient. These policies can also be distorted by lobbying, so the transition requires transparent rules and evaluation rather than assuming that public funding is automatically efficient.
The book’s reform argument is strongest when it treats institutions as connected. Removing one legal right while leaving costly approval rules, funding structures, or contractual practices untouched can create new problems. Direct subsidies and prizes may target research more precisely than monopoly, but they introduce their own risks: political favoritism, weak accountability, and pressure to fund fashionable projects. A credible transition would compare these mechanisms in specific sectors, preserve protections against fraud, and measure both innovation and access rather than treating abolition as a single switch.
Analysis
The book’s central contribution is to recast intellectual property as a contest between two ways of compensating creators: exclusion backed by law, and competitive returns generated by scarcity, expertise, speed, and service. Its most memorable cases make this comparison concrete. Watt’s patents connect legal control to delayed engineering improvements; open-source software and unprotected publishing show that copying can coexist with viable businesses; pharmaceutical history exposes how patent incentives can produce marketing and imitation as well as therapeutic advances.
The argument is strongest when it identifies mechanisms that standard incentive stories can overlook. Rights over foundational components can raise the cost of follow-on work. Broad claims can create defensive portfolios and deter entry. Retroactive copyright extension cannot motivate work already completed. These claims shift attention from the creator’s possible reward to the whole system’s output, access, and cumulative cost. Its evidence is less decisive than its rhetoric. Historical cases are rich but difficult to treat as controlled experiments. Patent law changes alongside market size, technology, regulation, and access to capital. Measures such as productivity can miss important outcomes, while patent counts can rise for strategic reasons. The authors acknowledge that indivisible projects serving small markets may fail to attract enough competitive investment, but they provide no universal test for how often that problem is binding. Their conclusion that intellectual monopolies should ultimately disappear therefore extends beyond what any single empirical measure can establish.
The most useful policy reading is comparative rather than absolute. Ask what incentive a proposed right supplies, what follow-on activity it blocks, and whether a less exclusionary mechanism can fund the relevant cost. Drug trials, software standards, books, and fashion have different bottlenecks, so one institutional remedy will not fit all. The book persuasively rejects the assumption that monopoly is the natural price of creativity. Its deeper challenge is to make policymakers demonstrate, sector by sector, that exclusion produces benefits that cannot be secured more openly and at lower social cost.
Review Summary
Against Intellectual Monopoly receives mostly positive reviews for its thorough examination of intellectual property rights. Readers appreciate the book's empirical approach, historical examples, and challenging arguments against patents and copyrights. Many find it eye-opening and thought-provoking, praising the authors' economic analysis. Some criticize the writing style as repetitive or dense. Several reviewers note the book's libertarian perspective, which some appreciate and others find limiting. Overall, it's considered an important contribution to the debate on intellectual property, though potentially controversial.
People Also Read
Glossary
Intellectual monopoly
Control over others’ copiesThe authors’ term for legal powers, especially patents and copyrights, that let a rights holder restrict how other people use their lawfully acquired copies of an idea or work. They distinguish this power from ordinary ownership of a particular copy, which lets its owner use or sell that copy without controlling everyone else’s.
IP-inefficiency
Innovation blocked by exclusionThe book’s label for social losses caused when intellectual property rights obstruct competition, follow-on innovation, adoption, or access. It includes more than higher prices: a patent can prevent a technically useful improvement, while copyright can keep an existing work unavailable for reuse. The authors use the term for costs they argue are difficult to see or measure.
Competitive rents
Returns from scarce capacityEarnings above the cost of producing an additional unit that arise when available productive capacity is limited relative to demand. In the authors’ model, an innovator can earn these returns while competitors invest in additional capacity. Such returns may reward early innovation without granting a legal right to exclude imitators.
Patent thicket
Overlapping claims on technologyA dense set of patents covering related elements of a product or process. A firm trying to develop a new product may need to identify and negotiate around numerous claims, sometimes held by competing firms. The book argues that this can encourage defensive patenting, cross-licensing, legal expense, and barriers to new entrants.
First-mover advantage
Benefits from arriving firstThe commercial benefits an innovator may receive by being the first to introduce a product or idea. The book identifies sources such as early sales, expertise, reputation, customer loyalty, and complementary services. These advantages can allow creators to earn revenue even when later competitors are legally free to copy or improve their work.
The Carnegie Survey
Firm survey of patent useA survey of U.S. firms cited in the book to examine how businesses protect returns from product and process innovation. Respondents rated methods such as secrecy, lead time, manufacturing, sales, and patents. The authors emphasize that firms often considered non-legal methods more effective than patents, and that patents were also used for bargaining and defensive purposes.
Copyleft
Share-alike software licensingA licensing approach used by some free and open-source software projects. It allows users to access, modify, and distribute software, while requiring that derivative versions remain available under the same terms. In the book, copyleft is presented as a way to support collaborative development and ensure that improvements remain accessible to users and future contributors.
FAQ
What's Against Intellectual Monopoly about?
- Critique of IP Laws: The book argues that intellectual property laws, such as patents and copyrights, hinder rather than promote innovation.
- Historical and Economic Analysis: It uses historical examples and economic theories to demonstrate how monopolistic practices can stifle competition and delay technological advancements.
- Authors' Perspective: Michele Boldrin and David K. Levine present a case for innovation thriving in competitive markets without the constraints of intellectual monopoly.
Why should I read Against Intellectual Monopoly?
- Challenge to Conventional Wisdom: The book offers a fresh perspective on intellectual property, questioning the necessity of patents and copyrights for innovation.
- Evidence-Based Arguments: It is grounded in historical examples and economic theory, providing a compelling case for re-evaluating current IP laws.
- Broader Implications: The discussions extend to cultural and social issues, making it relevant for those interested in law, economics, and creativity.
What are the key takeaways of Against Intellectual Monopoly?
- IP Inefficiency: The authors introduce "IP-inefficiency," highlighting the negative impact of intellectual monopolies on innovation and economic growth.
- Historical Context: They argue that many innovations occurred without patent protection, suggesting competition fosters creativity more effectively.
- Alternative Models: The book discusses collaborative innovation and open-source models as more effective than those protected by IP laws.
What are the best quotes from Against Intellectual Monopoly and what do they mean?
- "Intellectual property is an unnecessary evil.": This encapsulates the authors' thesis that the social costs of IP outweigh its benefits.
- "The industrial revolution was not driven by patents.": This challenges the narrative that patents were crucial for technological advancements during the industrial revolution.
- "Everyone wants a monopoly.": This highlights creators' desire to protect their work, but the authors argue such monopolies harm the economy and stifle competition.
How do Boldrin and Levine define "IP-inefficiency" in Against Intellectual Monopoly?
- Definition: IP-inefficiency refers to the negative consequences of intellectual monopolies, including stifled innovation and reduced economic growth.
- Mechanisms of Harm: Monopolists often focus on suppressing competition rather than innovating, leading to resource waste and technological slowdown.
- Real-World Examples: The book cites the pharmaceutical industry, where patent protections lead to high prices and limited access to essential drugs.
What historical examples do the authors use to support their arguments in Against Intellectual Monopoly?
- James Watt's Patents: Watt's patents on the steam engine delayed innovation and efficiency improvements, illustrating monopolistic practices' detrimental effects.
- The Cotton Gin: Eli Whitney's experience shows how enforcing patent rights can hinder broader industry growth and innovation.
- Open Source Software: The success of the open-source movement is highlighted as a modern example of rapid innovation without IP protections.
How do the authors suggest innovation can thrive without intellectual property in Against Intellectual Monopoly?
- Emphasis on Competition: Competition encourages innovation by allowing multiple players to improve upon existing ideas without patent constraints.
- Collaborative Innovation: They advocate for sharing information and building upon each other's work, leading to faster advancements and better products.
- Market Dynamics: In a competitive market, first mover advantage and capturing social surplus incentivize innovation without monopolistic protections.
What reforms do Boldrin and Levine suggest for intellectual property laws?
- Gradual Reduction of Patent Terms: They advocate for reducing patent terms to encourage competition and innovation, suggesting a cut to four years for pharmaceuticals.
- Public Financing of Clinical Trials: Propose government funding for clinical trials to reduce financial burdens on pharmaceutical companies and improve drug accessibility.
- Mandatory Licensing: Recommend implementing mandatory licensing for unused patents to ensure innovations can be utilized and built upon by others.
How does Against Intellectual Monopoly address the pharmaceutical industry specifically?
- High Costs of Drug Development: The authors highlight the inflated costs of bringing new drugs to market due to the patent system.
- Impact on Innovation: Patents do not significantly increase pharmaceutical innovation rates, often leading to redundant "me-too" drugs.
- Access to Medicines: Patent protections can limit access to essential medicines, particularly in developing countries, and the book suggests reforms to improve this.
What is the authors' stance on the relationship between IP laws and economic growth?
- Negative Correlation: Stronger IP laws do not correlate with economic growth; competition is a more effective driver of innovation and prosperity.
- Historical Evidence: Examples show countries with less stringent IP protections experienced significant economic growth and innovation.
- Call for a New Paradigm: The authors advocate for a shift in how society views IP, promoting competition and collaboration over monopolistic practices.
How do the authors view imitation in the context of innovation?
- Positive Role of Imitation: Imitation is a vital part of innovation, allowing new entrants to improve upon existing ideas and products.
- Economic Development: Societies benefit from a culture of imitation, fostering competition and driving economic growth.
- Contrast with IP Laws: IP laws discourage imitation, stifling the competition that leads to innovation.
How do Boldrin and Levine address the argument that patents are necessary for funding innovation in Against Intellectual Monopoly?
- Counter-Argument: They challenge the notion that patents are essential for securing funding, citing successful innovations without patent protection.
- Alternative Funding Models: Suggest mechanisms like venture capital and market demand can incentivize innovation without monopolistic protections.
- Historical Evidence: Examples of industries thriving without patents demonstrate that innovation can be funded through competitive markets.
Download PDF
Download EPUB
.epub digital book format is ideal for reading ebooks on phones, tablets, and e-readers.